Dulaglutide Dulaglutide (Trulicity) is administered subcutaneously at a maximum dose of 1.5 mg once weekly, and available on license since 2014 for people with T2D as monotherapy in those who cannot take metformin or as add-on treatment in people using oral agents and/or insulin
Their program is supportive, flexible, and truly designed for long-term success, not just temporary results." Agnes, 62 QUALITY TESTED We only work with US-licensed pharmacies that prioritize strict quality control standards, so you can count on purity, potency, and safety
W., Swanson, J
Side effects and safety Headache, flushing, and a stuffy nose are common side effects
Recently, a study published in June 2022 showed that treatment with Wegovy reduced the 10-year-risk of developing diabetes by around 60%
This allows Mounjaro to be more effective as well as enabling longer term effects (which we will cover shortly)